Search hospitals > Pennsylvania > Abington
Abington Memorial Hospital
Claim this profileAbington, Pennsylvania 19001
Global Leader in Cancer
Global Leader in Ovarian Cancer
Conducts research for Recurrence
Conducts research for Ovarian Tumors
Conducts research for Adenocarcinoma
304 reported clinical trials
9 medical researchers
Summary
Abington Memorial Hospital is a medical facility located in Abington, Pennsylvania. This center is recognized for care of Cancer, Ovarian Cancer, Recurrence, Ovarian Tumors, Adenocarcinoma and other specialties. Abington Memorial Hospital is involved with conducting 304 clinical trials across 318 conditions. There are 9 research doctors associated with this hospital, such as Mark Shahin, MD, Russell J Schilder, MD, Steven J. Cohen, and Donald Haas.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Ovarian Cancer
Global LeaderStage IV
Stage III
BRCA1 positive
Top PIs
Mark Shahin, MDAsplundh Cancer Pavilion1 year of reported clinical research
Studies Cancer
Studies Ovarian Cancer
18 reported clinical trials
60 drugs studied
Russell J Schilder, MDThomas Jefferson University1 year of reported clinical research
Studies Ovarian Cancer
Studies Endometrioid Carcinoma
10 reported clinical trials
16 drugs studied
Steven J. CohenAsplundh Cancer Pavilion5 years of reported clinical research
Studies Colorectal Cancer
Studies Cancer
6 reported clinical trials
16 drugs studied
Donald HaasAbington Memorial Hospital2 years of reported clinical research
Studies Heart Failure
Studies Cardiomyopathy
5 reported clinical trials
8 drugs studied
Clinical Trials running at Abington Memorial Hospital
Stroke
Heart Failure
Ovarian Tumors
Ovarian Cancer
Ovarian Carcinoma
Testicular Carcinoma
Ovarian Choriocarcinoma
Pancreatic Cancer
Fallopian Tube Cancer
Germ Cell Tumors
Anti-Coagulant + Anti-Platelet Therapy
for Stroke Prevention
The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, intracerebral hemorrhage, or vascular death.
Recruiting2 awards Phase 36 criteria
Apixaban vs Aspirin
for Stroke Prevention in Atrial Fibrillation After Brain Bleed
Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in better functional outcomes as measured by the modified Rankin Scale.
Recruiting1 award Phase 36 criteria
Milvexian
for Stroke
This trial is testing whether milvexian can help prevent another stroke in people who have already had one by stopping blood clots from forming. Milvexian may reduce the risk of stroke without significant bleeding.
Recruiting1 award Phase 35 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Abington Memorial Hospital?
Abington Memorial Hospital is a medical facility located in Abington, Pennsylvania. This center is recognized for care of Cancer, Ovarian Cancer, Recurrence, Ovarian Tumors, Adenocarcinoma and other specialties. Abington Memorial Hospital is involved with conducting 304 clinical trials across 318 conditions. There are 9 research doctors associated with this hospital, such as Mark Shahin, MD, Russell J Schilder, MD, Steven J. Cohen, and Donald Haas.